ongentys 50 mg
truemed ltd, israel - opicapone - hard capsule - opicapone 50 mg - opicapone - ongentys is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.
natrovit pulver für ein konzentrat zur herstellung einer infusionslösung
prelafal forte® tablets
akromed -
co-careldopa 10mg/100mg tablets
brillpharma (ireland) limited inniscarra, main street, rathcoole, co. dublin, ireland - carbidopa, levodopa - tablet - carbidopa 10.8 mg levodopa 100 mg - anti-parkinson drugs
co-careldopa 12.5mg/50mg tablets
brillpharma (ireland) limited inniscarra, main street, rathcoole, co. dublin, ireland - carbidopa, levodopa - tablet - carbidopa 12.5 mg levodopa 50 mg - anti-parkinson drugs
co-careldopa 25mg/250mg tablets
brillpharma (ireland) limited inniscarra, main street, rathcoole, co. dublin, ireland - carbidopa, levodopa - tablet - carbidopa 25 mg levodopa 250 mg - anti-parkinson drugs
co-careldopa
bristol laboratories limited - carbidopa, levodopa - tablet - carbidopa 10.8 milligram(s) ; levodopa 100 milligram(s) - anti-parkinson drugs
co-careldopa
bristol laboratories limited - carbidopa, levodopa - tablet - carbidopa 13.5 milligram(s) ; levodopa 50 milligram(s) - anti-parkinson drugs
co-careldopa
bristol laboratories limited - carbidopa, levodopa - tablet - carbidopa 27 milligram(s) ; levodopa 250 milligram(s) - anti-parkinson drugs